Return-Path: <mail@newscpt17.de>
Received: from vps.transocean.com
	by vps.transocean.com with LMTP id 6JzuHd/jYVocKwAAInt2oQ
	; Fri, 19 Jan 2018 04:26:07 -0800
Return-path: <mail@newscpt17.de>
Envelope-to: JOHN@TRANSOCEAN.COM
Delivery-date: Fri, 19 Jan 2018 04:26:07 -0800
Received: from mx.newscpt17.de ([185.11.253.151]:52316)
	by vps.transocean.com with esmtp (Exim 4.89_1)
	(envelope-from <mail@newscpt17.de>)
	id 1ecVk5-0002rm-Iv
	for JOHN@TRANSOCEAN.COM; Fri, 19 Jan 2018 04:26:07 -0800
Content-Type: multipart/mixed; boundary="===============5149483069378155146=="
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=newscpt17.de;
	s=default; t=1516364716;
	bh=DXeBEYqwjMQNKceKXdrG3X+4M+RvaXxC9OLyaf7kjA4=;
	h=X-CSA-Complaints:Reply-To:Subject:From:To:List-Id:
	 List-Unsubscribe:Date:Reply-To:From:Subject:Date:To:
	 List-Unsubscribe:List-Id:X-CSA-Complaints;
	b=YGefJ4BCFY7lYyq1BZ6ofNMKJTIaQQOMIaE4piCNNRgveZJ8F6Zj3eMSawiPz5yu+
	 hZ4vUR4zVm6SGo2LHg1JEeQUOg+H3f1Za/JVljN6Ds/Kq+sNnX1S+i0Lm0ARgbb8FN
	 Ni1GDrPj4EEOID+frOWmcrU+zY9C9sDsGlvpi54s=
MIME-Version: 1.0
X-CSA-Complaints: <whitelist-complaints@eco.de
 (mailto:whitelist-complaints@eco.de)>
Reply-To: Microbial Pathogens Detection <Alinas@Fda-trainings.com>
Subject: FDA Validation Criteria and Guidance for FVM Microbiology
From: Microbial Pathogens Detection <Alinas@Fda-trainings.com>
To: <JOHN@TRANSOCEAN.COM>
BOUNCED_id_tdat_newsletter: 3495135
List-Id: <475626380>
BOUNCED_id_tdat_nl_subscriber: 475626380
bounced_nl: true
BOUNCED_tdat_nl_subscriber_pw: a2fbbf1269b6e082d34a526d26fed577
List-Unsubscribe: <http://ea.newscpt.com/_u/5cf4f8766c1461757e5bbdd4209982af.html>
hermes_uid: 6085d37921f3e6551f854f834b5307a4
Date: Fri, 19 Jan 2018 12:25:16 -0000
Message-Id: <20180119122516.502B424160C@mx.newscpt17.de>
X-Spam-Status: No, score=2.4
X-Spam-Score: 24
X-Spam-Bar: ++
X-Ham-Report: Spam detection software, running on the system "vps.transocean.com",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 
 Content preview:  Sie können diesen HTML Newsletter nicht sehen? Dann verpassen
    Sie wirklich etwas. Rufen Sie folgende URL auf, um den Newsletter anzuzeigen:
    http://ea.newscpt17.de/_ns/5cf4f8766c1461757e5bbdd4209982af.html [...] 
 
 Content analysis details:   (2.4 points, 3.0 required)
 
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  0.0 URIBL_BLOCKED          ADMINISTRATOR NOTICE: The query to URIBL was blocked.
                             See
                             http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
                              for more information.
                             [URIs: audioeducator.com]
  0.0 T_SPF_HELO_TEMPERROR   SPF: test of HELO record failed (temperror)
 -0.0 T_RP_MATCHES_RCVD      Envelope sender domain matches handover relay
                             domain
  0.2 HEADER_FROM_DIFFERENT_DOMAINS From and EnvelopeFrom 2nd level mail
                             domains are different
 -0.0 SPF_PASS               SPF: sender matches SPF record
  0.8 MPART_ALT_DIFF         BODY: HTML and text parts are different
  0.8 BAYES_50               BODY: Bayes spam probability is 40 to 60%
                             [score: 0.4621]
  0.0 HTML_MESSAGE           BODY: HTML included in message
  0.0 HTML_FONT_SIZE_LARGE   BODY: HTML font size is large
  0.6 KAM_ADVERT2            RAW: This is probably an unwanted commercial email...
 -0.1 DKIM_VALID             Message has at least one valid DKIM or DK signature
  0.1 DKIM_SIGNED            Message has a DKIM or DK signature, not necessarily valid
  0.0 T_HTML_TAG_BALANCE_CENTER Malformatted HTML
X-Spam-Flag: NO

--===============5149483069378155146==
Content-Type: multipart/alternative;
 boundary="===============8233202293306775669=="
MIME-Version: 1.0

--===============8233202293306775669==
MIME-Version: 1.0
Content-Transfer-Encoding: 8bit
Content-Type: text/plain; charset="utf-8"

Sie können diesen HTML Newsletter nicht sehen? Dann verpassen Sie wirklich etwas. Rufen Sie folgende URL auf, um den Newsletter anzuzeigen:
http://ea.newscpt17.de/_ns/5cf4f8766c1461757e5bbdd4209982af.html

Um sich von diesem Newsletter abzumelden, rufen Sie folgende URL auf:
http://ea.newscpt17.de/_u/5cf4f8766c1461757e5bbdd4209982af.html

///

Can't see this html newsletter? You're really missing out. Visit this URL to view the newsletter:
http://ea.newscpt17.de/_ns/5cf4f8766c1461757e5bbdd4209982af.html

To instantly unsubscribe from our newsletter, visit this URL:
http://ea.newscpt17.de/_u/5cf4f8766c1461757e5bbdd4209982af.html
--===============8233202293306775669==
MIME-Version: 1.0
Content-Transfer-Encoding: 8bit
Content-Type: text/html; charset="utf-8"

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html>
<head><meta name="format-detection" content="telephone=no"><link rel="stylesheet" href="http://ea.newscpt17.de/_na/5cf4f8766c1461757e5bbdd4209982af.css" type="text/css" charset="utf-8">
<meta content="text/html;charset=UTF-8" http-equiv="content-type" />
<title>How the FDA are Trained for Medical Device Inspections VBC</title>
  <style>
body {margin:0px; padding: 0px;}
  table {border-collapse: collapse;}
  td {color: #000000;}
  .responsive-image img {
  height: auto !important;
  max-width: 100% !important;
  width: 100% !important;
  }
    
    a {
    text-decoration:none;
  }
    
@media only screen and (max-width: 595px) {
  body,table,td,p,a,li,blockquote {
  -webkit-text-size-adjust:none !important;
  }
  table {width: 100% !important;}
 
  .responsive-image img {
  height: auto !important;
  max-width: 100% !important;
  width: 100% !important;
  }
    .removeborder
    { border:none !important;
    }
  }
  </style>
</head>
<body>
<table width="100%%" border="0" cellspacing="0" cellpadding="0">
  <tr>
  <td align="center" style="padding:10px; padding-bottom:0px;"><strong><font face="Times New Roman, Times, serif" size="6" color="#00599c">Analytical Method Validation for the Detection of<br />
Microbial Pathogens in Foods and Feeds</font></strong></td>
  </tr>
 <tr>
  <td align="center" style="padding:10px;">
  <strong><font face="Times New Roman, Times, serif" size="4" color="#00599c">Presented By: 
Angela Bazigos</font></strong> </td>
  </tr>
  
  <tr>
  <td align="center" style="padding:10px;">
  <strong><font face="Times New Roman, Times, serif" size="4" color="#00599c">Virtual Boot C&agrave;mp | Date: Tuesday, February 06, 2018 | Length: 180 minutes | Time: 12:00 PM EST - 3:20 PM EST</font></strong> </td>
  </tr>
  <tr>
  <td align="center"><strong><font face="Times New Roman, Times, serif" size="6" color="#00599c">
  <a href="http://ea.newscpt17.de/_la.php?&nid=3495135&sid=475626380&lid=14812760&enc=68747470733a2f2f7777772e617564696f6564756361746f722e636f6d&tg=virtualbootcamp/analytical-method-validation-for-microbial-pathogens?utm_medium=email&utm_source=angela&utm_campaign=EFOOVBEM_CE" style="color:#00599c;"><u><em>Register Now</em></u></a></font></strong></td>
  </tr>
  
  <tr>
  <td style="padding:10px;">
  <font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#535353"><strong>


</strong><br /><br />
When a company is tasked with ensuring the safety of the nation’s food supply, it is imperative that laboratory methods needed to support regulatory compliance, investigations and enforcement, meet the highest analytical performance standards appropriate for their intended purposes, according to the FDA. For the development of standardized validation requirements for all regulatory methods used to d&egrave;tect microbial pathogens and in your laboratories, it is critical that you continue to meet the highest standards possible. <br /><br />
<strong>Why You Should Attend</strong><br /><br />
Join this virtual boot c&agrave;mp, where food safety expert <strong>Angela Bazigos</strong> will cover the latest FDA thinking and guidance documents to assist you in re-establishing the requirements that need to be fulfilled in the evaluation for microbial methods used in your testing laboratories. This boot c&agrave;mp will also re-establish performance evaluation (verification and validation) criteria, necessary for the use of commercially-available diagnostic test kits and platforms.<br /><br />

Angela will describe the FDA’s evaluation criteria for methods to d&egrave;tect, identify and quantify all microbial analytes that may now be, or have the potential to be, associated with foods and feeds, i.e. any microbiological organism of interest (target organism) or the genetic material i.e. DNA, RNA, toxins, antigens or any other product of these organisms.<br /><br />

This boot c&agrave;mp will cover the methodologies that are also used by FDA labs. FDA applies them to educat&igrave;on, inspections, data collections, standard setting, investigation of outbreaks and enforcement actions.</font></td>
  </tr>
  
  <tr>
<td style="padding:10px;"><strong><font face="Verdana" size="3" color="#535353">SESSION 1:  </font></strong></td>
</tr>
<tr>
<td style="padding:10px;"><strong><font face="Verdana" size="2" color="#535353">Session Timings: 12:00 PM EST to 1:00 PM EST | Duration: 60 minutes </font></strong></td>
</tr>
  
  
  <tr>
    <td style="padding:10px;"><font face="Verdana" size="2" color="#535353">This session will discuss FDA validation criteria and guidance for all FVM-developed or any existing method(s) that has been significantly modified. </font></td>
  </tr>
  <tr>
<td style="padding:10px;"><strong><font face="Verdana" size="2" color="#535353">Session Highlights</font></strong></td>
</tr>
 
<tr>
<td style="padding:10px; padding-top:0px;">
     
     <ul>
        

    <li><font face="Verdana" size="2" color="#535353"><strong>Introduction</strong></font></li>
    <ul>
        <li><font face="Verdana" size="2" color="#535353">Purpose and scope</font></li>
        <li><font face="Verdana" size="2" color="#535353">Administrative authority and responsibilities</font></li>
        <li><font face="Verdana" size="2" color="#535353">General responsibilities of the originating laboratory</font></li>
        <li><font face="Verdana" size="2" color="#535353">Method validation definition</font></li>
        <li><font face="Verdana" size="2" color="#535353">Applicability</font></li>
        <li><font face="Verdana" size="2" color="#535353">Requirements</font></li>
        </ul>
    <li><font face="Verdana" size="2" color="#535353"><strong>Criteria and guidance for the validation of FDA-related methods</strong></font></li>
    <ul>
        <li><font face="Verdana" size="2" color="#535353">Validation: Definitions</font></li>
        <ul>
            <li><font face="Verdana" size="2" color="#535353">The reference method</font></li>
            <li><font face="Verdana" size="2" color="#535353">The alternate method</font></li>
            <li><font face="Verdana" size="2" color="#535353">The originating laboratory</font></li>
            <li><font face="Verdana" size="2" color="#535353">The collaborating laboratory</font></li>
            </ul>
        <li><font face="Verdana" size="2" color="#535353">The method validation process</font></li>
        <ul>
            <li><font face="Verdana" size="2" color="#535353">Emergency use</font></li>
            <li><font face="Verdana" size="2" color="#535353">Non-emergency use</font></li>
            </ul>
        <li><font face="Verdana" size="2" color="#535353">Validation criteria</font></li>
        <ul>
            <li><font face="Verdana" size="2" color="#535353">Validation criteria for qualitative methods to d&egrave;tect conventional microbial food-borne pathogens</font></li>
            <li><font face="Verdana" size="2" color="#535353">Validation criteria for identification methods</font></li>
            <li><font face="Verdana" size="2" color="#535353">Validation criteria for quantifiable methods to d&egrave;tect conventional microbial food-borne pathogens</font></li>
            </ul>
        <li><font face="Verdana" size="2" color="#535353">Method validation operational aspects</font></li>
        <ul>
           <li><font face="Verdana" size="2" color="#535353">General considerations</font></li>
            <li><font face="Verdana" size="2" color="#535353">Assessment of validation results</font></li>
</ul></ul>
    </ul>  </td>
</tr>

<tr>
<td style="padding:10px;"><strong><font face="Verdana" size="3" color="#535353">SESSION 2:  </font></strong></td>
</tr>
<tr>
<td style="padding:10px;"><strong><font face="Verdana" size="2" color="#535353">Session Timings: 01:10 PM EST to 02:10 PM EST | Duration: 60 minutes </font></strong></td>
</tr>
  
  
  <tr>
    <td style="padding:10px;"><font face="Verdana" size="2" color="#535353">This session will cover the FDA’s guidelines intended to support method validation efforts for developers of molecular-based assays e.g. PCR, to be used to confirm the identity of exclusion of isolated colonies. The methodologies from this session can be used for either conventional or real time PCR assays. The session will also discuss how to confirm that results obtained by commercially-available kit, are comparable to or exceed those obtained using the reference method. </font></td>
  </tr>
  <tr>
<td style="padding:10px;"><strong><font face="Verdana" size="2" color="#535353">Session Highlights</font></strong></td>
</tr>

  <tr>
    <td style=" padding:10px;">
   
          <ul>
    <li><font face="Verdana" size="2" color="#535353"><strong>Criteria and guidance for the validation of FDA-related molecular-based assays</strong></font></li>
    <ul>
        <li><font face="Verdana" size="2" color="#535353">Inclusivity and exclusivity</font></li>
        <li><font face="Verdana" size="2" color="#535353">Target genes and controls</font></li>
        <li><font face="Verdana" size="2" color="#535353">Comparison to the reference method</font></li>
        </ul>
    <li><font face="Verdana" size="2" color="#535353"><strong>Criteria and guidance for the validation and verification of commercially available microbiological diagnostic kits and platforms</strong></font></li>
    <ul>
        <li><font face="Verdana" size="2" color="#535353">Definitions</font></li>
        <ul>
            <li><font face="Verdana" size="2" color="#535353">Validation of an alternative method</font></li>
            <li><font face="Verdana" size="2" color="#535353">Verification</font></li>
          </ul>  
        <li><font face="Verdana" size="2" color="#535353">Criteria</font></li>
        <ul>
            <li><font face="Verdana" size="2" color="#535353">Commercially-available microbiological diagnostic kits, whose performance parameters have been fully validated in a multi-laboratory collaborative study, monitored and evaluated by an independent accrediting body e.g. AOAC-OMA, AFNOR, etc.</font></li>
            <li><font face="Verdana" size="2" color="#535353">Commercially-available microbiological diagnostic kits, whose performance parameters are supported by data obtained through an independent laboratory validation protocol and evaluated by an independent accrediting body e.g. AOAC-RI.</font></li>
</ul></ul>
        </ul>    </td>
  </tr>
  
  <tr>
<td style="padding:10px;"><strong><font face="Verdana" size="3" color="#535353">SESSION 3: </font></strong></td>
</tr>
<tr>
<td style="padding:10px;"><strong><font face="Verdana" size="2" color="#535353">Session Timings: 02:20 PM EST to 03:20 PM EST | Duration: 60 minutes </font></strong></td>
</tr>
  
  
  <tr>
    <td style="padding:10px;"><font face="Verdana" size="2" color="#535353">Modifications to an existing validated method may be made for any number of reasons and may or may not affect the established validated performance parameters of the original method, as per the FDA. There is no “one size fits all” rule or set of rules to govern how a modification will be addressed. This session will describe how such modifications are evaluated and the path to ensuring that the validated state remains intact. The session will also present some SOPs that can be used in your laboratory to meet the method validation requirements for the detection of microbial pathogens in foods and feeds. </font></td>
  </tr>
  <tr>
<td style="padding:10px;"><strong><font face="Verdana" size="2" color="#535353">Session Highlights</font></strong></td>
</tr>
  
  <tr>
    <td style=" padding:10px;">
          
          <ul>
    <li><font face="Verdana" size="2" color="#535353"><strong>Method modification and method extension criteria for existing validated microbiology methods</strong></font></li>
    <ul>
        <li><font face="Verdana" size="2" color="#535353">Matrix extension</font></li>
        <ul>
            <li><font face="Verdana" size="2" color="#535353">Matrix extension guidance for new foods from the same category used for the original or subsequent validation studies</font></li>
            <li><font face="Verdana" size="2" color="#535353">Matrix extension guidance for new foods from a different category than that used for the original method validation study</font></li>
            </ul>
        <li><font face="Verdana" si	ze="2" color="#535353">Platform extension</font></li>
        </ul>
    <li><font face="Verdana" size="2" color="#535353"><strong>SOPs</strong></font></li>
    <ul>
        <li><font face="Verdana" size="2" color="#535353">Method development, implementation and validation SOP</font></li>
        <li><font face="Verdana" size="2" color="#535353">FVM microbiology method validation study application</font></li>
 </ul>
        </ul>
    
    </td>
  </tr>
  <tr>
  <td  align="center" style=" padding:10px;"> <font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#535353"><em>Get answers to your questions in the Q&A directly from the speaker</em></font></td>
  </tr>
  

  <tr>
  <td align="center"><strong><em><font face="Times New Roman, Times, serif" size="6" color="#f9417d"><a href="http://ea.newscpt17.de/_la.php?&nid=3495135&sid=475626380&lid=14812760&enc=68747470733a2f2f7777772e617564696f6564756361746f722e636f6d&tg=virtualbootcamp/analytical-method-validation-for-microbial-pathogens?utm_medium=email&utm_source=angela&utm_campaign=EFOOVBEM_CE" style="color:#00599c;"><u>Register Now</u></a></font></em></strong></td>
  </tr>

<tr>
  <td  align="center" style=" padding:10px;"><font face="Times New Roman, Times, serif" size="4" color="#535353">✆ Call Now: <strong>1-866-458-2965</strong>
and mention <strong style="color:#535353;">EFOOVBEM_CE</strong> or email us at 
 </font><font face="Times New Roman, Times, serif" size="4"><a href="mailto:customerservice@audioeducator.com" style="color:#535353; text-decoration:underline;"><strong>customerservice@audioeducator.com</strong></a></font></td>
</tr>
</table>
 <p align="center"><font color="#000000" size="1" face="Arial">We hope you found this message to be useful.<br/>If you don’t wish to receive any further communication, please click the unsubscribe link below. 
Your request will be processed within 10 days. This is an advertisement. <br />
Audio Educator | 2222 Sedwick Rd, Durham NC 27713 | 1-866-458-2965 <br />
This message has been sent by Audio Educator.</font></p>
<img src="http://ea.newscpt17.de/_na/5cf4f8766c1461757e5bbdd4209982af.gif" width="1" height="1"></body> </html>
<CENTER><a href="http://ea.newscpt17.de/_u/5cf4f8766c1461757e5bbdd4209982af.html">UNSUBSCRIBE</a>

--===============8233202293306775669==--

--===============5149483069378155146==--
